Skip to main content
THERACRYF PLC logo

THERACRYF PLC — Investor Relations & Filings

Ticker · TCF ISIN · GB00BSVYN304 LEI · 213800NO3E6TSTQO8K20 IL Professional, scientific and technical activities
Open in API
Filings indexed 361 across all filing types
Latest filing 2024-07-18 AGM Information
Country GB United Kingdom
Listing IL TCF

About THERACRYF PLC

https://theracryf.com/

TheraCryf PLC is a clinical-stage therapeutics company focused on developing a new generation of innovative medicines for behavioural brain disorders and oncology. The company's research and development efforts are centered on sulforaphane-based compounds. Its primary therapeutic focus is on conditions such as opioid and alcohol abuse, binge eating disorder, anxiety, and fatigue. TheraCryf's business strategy is to generate compelling clinical data for its drug candidates with the goal of partnering its programs with larger pharmaceutical companies for late-stage development and commercialization.

Recent filings

Filing Released Lang Actions
Result of AGM
AGM Information Classification · 99% confidence The document is an RNS announcement (indicated by 'RNS Number : 9906W' and the LSE footer). The primary subject is the 'Result of AGM' and the announcement states that 'all resolutions were passed'. This directly relates to the outcome of a shareholder meeting. While it mentions the AGM result, the core purpose of this specific RNS filing is to report the voting outcomes. This aligns best with the Declaration of Voting Results & Voting Rights Announcements (DVA). Although it mentions AGM, the content is the result, not the presentation material (AGM-R) or the proxy solicitation (PSI). Given the explicit mention of 'Result of AGM' and the voting outcome, DVA is the most precise fit.
2024-07-18 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with "RNS Number : 7755W" and contains standard regulatory notification tables, specifically a "TR-1: Standard form for notification of major holdings." This form details an acquisition or disposal of voting rights by an individual (James Robert Kight) and reports the resulting percentage of voting rights (8.09647%). The footer confirms the information is provided by RNS, the news service of the London Stock Exchange, which acts as a Primary Information Provider. This type of filing, reporting changes in significant share ownership, directly corresponds to the Major Shareholding Notification category (MRQ). Although it is distributed via RNS, the content is specific enough to warrant the MRQ classification over the general RNS fallback.
2024-07-17 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 6291W' and contains the standard boilerplate text indicating it is provided by RNS, the news service of the London Stock Exchange, which acts as a Primary Information Provider. The content itself is a 'TR-1: Standard form for notification of major holdings' dated 16 July 2024, detailing an acquisition of voting rights that crossed a threshold (from 4.79% to 5.42%). This type of mandatory disclosure regarding changes in significant share ownership perfectly matches the definition for Major Shareholding Notification (MRQ). Although it is an RNS filing, MRQ is the more specific category.
2024-07-16 English
Group of companies' accounts made up to 2024-03-31
Regulatory Filings
2024-07-15 English
Publication of peer-reviewed data on SFX-01
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated '10 July 2024'. It announces the 'Publication of peer reviewed data' regarding a drug candidate (SFX-01) and includes quotes from company executives and collaborators. The footer explicitly states, 'This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange.' This structure is characteristic of a general regulatory news service announcement, which is best classified as a Regulatory Filing (RNS) when the content is a specific operational update that doesn't fit the more specific categories like ER, DIV, or DIRS. It is not a full financial report (10-K, IR) or a presentation (IP).
2024-07-10 English
Annual Financial Report and Notice of AGM
Report Publication Announcement Classification · 100% confidence The document is a short announcement (3688 characters) identified by the RNS Number, which is characteristic of regulatory news services. The text explicitly states that the 'Annual Report and Accounts for the year ended 31 March 2024 have been posted to shareholders and are now available on the Company website.' It also announces the date and location of the AGM. Because the document is an announcement *about* the publication of the Annual Report and the AGM details, rather than the full report itself (10-K) or the AGM presentation (AGM-R), it fits the definition of a Report Publication Announcement (RPA). It also contains AGM details, but the primary function here is announcing the availability of reports and the upcoming meeting notice, making RPA the most precise fit based on the 'MENU VS MEAL' rule for short announcements.
2024-06-21 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.